title: Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.
authors.affiliation: Baylor College of Medicine, Houston, TX 77054, USA. stosicmil@yahoo.com
authors.forename: M
authors.initials: M
authors.lastname: Stosic
authors.forename: P
authors.initials: P
authors.lastname: De Jesus
authors.forename: J
authors.initials: J
authors.lastname: McCarthy
authors.forename: G
authors.initials: G
authors.lastname: Hutton
authors.forename: V
authors.initials: V
authors.lastname: Rivera
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D000069442:Natalizumab; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069442:Natalizumab